/THNR
THNR Stock - Amplify Weight Loss Drug & Treatment ETF
Financial Services|Asset ManagementAMEX
$25.13+0.00%
+$0.00 (+0.00%) • Dec 19
71
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.68
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $27.65
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for THNR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$24.88 – $25.39
TARGET (TP)$28.90
STOP LOSS$23.12
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.51
52W High$26.27
52W Low$18.56
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
THNRLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about THNR
What is THNR's current stock price?
Amplify Weight Loss Drug & Treatment ETF (THNR) is currently trading at $25.13 per share. The stock has moved +0.00% today.
What is the analyst price target for THNR?
No analyst price targets are currently available for this stock.
What sector is Amplify Weight Loss Drug & Treatment ETF in?
Amplify Weight Loss Drug & Treatment ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the AMEX exchange.
What is THNR's market cap?
Amplify Weight Loss Drug & Treatment ETF has a market capitalization of $0.00 billion, making it a small-cap company.
Does THNR pay dividends?
No, Amplify Weight Loss Drug & Treatment ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBEDZ
AdvisorShares Hotel ETF
$34.75
Mkt Cap: $0.0B
CDIG
City Different Investments Global Equity ETF
$25.05
Mkt Cap: $0.0B
CRED
Columbia ETF Trust I - Columbia Research Enhanced Real Estate ETF
$19.82
Mkt Cap: $0.0B
DUKX
Ocean Park International ETF
$26.09
Mkt Cap: $0.0B
EAFG
Pacer Developed Markets Cash Cows Growth Leaders ETF
$23.48
Mkt Cap: $0.0B
EATZ
AdvisorShares Restaurant ETF
$27.06
Mkt Cap: $0.0B
GEND
Genter Capital Dividend Income ETF
$11.55
Mkt Cap: $0.0B
ION
Proshares S&P Global Core Battery Metals ETF
$49.76
Mkt Cap: $0.0B
KPRO
KraneShares 100% KWEB Defined Outcome January 2027 ETF
$30.76
Mkt Cap: $0.0B
MCHS
Matthews China Discovery Active ETF
$32.37
Mkt Cap: $0.0B
Explore stocks similar to THNR for comparison